Alleviation of isolated nail lichen planus by the JAK1/2 inhibitor Baricitinib: a case report

被引：4
|
作者：
He, Juan [1 ]
Weng, Tengyu [1 ]
Zhu, Wenwei [1 ]
Yang, Yi [2 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Dermatol, Beijing, Peoples R China
[2] Third Med Ctr Chinese Peoples Liberat Army, Dept Dermatol, Beijing, Peoples R China
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2023年 / 34卷 / 01期
关键词：
D O I：
10.1080/09546634.2023.2274816
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Effective treatment of nail lichen planus with the JAK inhibitor baricitinib
    Chim, Ivana
    Sinclair, Rodney
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 52 - 53
  • [2] Alleviation of erosive oral and esophageal lichen planus by the JAK1 inhibitor upadacitinib
    Kooybaran, Neda Rahbar
    Petzold, Golo
    Stroebel, Philipp
    Schoen, Michael P.
    Moessner, Rotraut
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (12):
  • [3] Effective treatment of oral lichen planus with the JAK inhibitor baricitinib
    Moussa, Anthony
    Colla, Themis
    Morrison, Brendan
    Sinclair, Rodney
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (02) : 276 - 277
  • [4] Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review
    He, Juan
    Yang, Yi
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [5] Rapid and Sustained Improvement of Lichen Planus Pemphigoides With the JAK1 Inhibitor Upadacitinib
    Gueissaz, Louise
    Wolf, Ronald
    Schlapbach, Christoph
    JEADV CLINICAL PRACTICE, 2024,
  • [6] Esophageal lichen planus successfully treated with the JAK1/3 inhibitor tofacitinib
    Kooybaran, Neda Rahbar
    Petzold, Golo
    Schoen, Michael P.
    Moessner, Rotraut
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (06): : 858 - 860
  • [7] Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
    Jabbari, Ali
    Dai, Zhenpeng
    Xing, Luzhou
    Cerise, Jane E.
    Ramot, Yuval
    Berkun, Yackov
    Sanchez, Gina A. Montealegre
    Goldbach-Mansky, Raphaela
    Christiano, Angela M.
    Clynes, Raphael
    Zlotogorski, Abraham
    EBIOMEDICINE, 2015, 2 (04): : 351 - 355
  • [8] Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report
    Fan, Birao
    Wang, Mingyue
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [9] Remission of necrobiosis lipoidica diabeticorum with a JAK1/2 inhibitor: A case report
    Barbet-Massin, M. -A.
    Rigalleau, V.
    Blanco, P.
    Mohammedi, K.
    Poupon, P.
    Belin, E.
    Poursac, N.
    Cadart, O.
    Blanco, L.
    DIABETES & METABOLISM, 2021, 47 (04)
  • [10] Rapid and sustained improvement of cutaneous lichen planus with oral JAK1 inhibitors
    Boll, Simone L.
    Zahn, Carole A.
    Schlapbach, Christoph
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : E82 - E85
12345